loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

List of Certificates of Suitability (CEPs) for r1_cep_2012_170___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL (1)

filter

01 Olmesartan medoxomil (1)

filter

01 Israel (1)

filter

01 Valid (1)

URL Supplier Web Content
R1-CEP 2012-170 - Rev 01
Valid
Chemical
2022-05-25
2600
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for Certificates of Suitability (CEPs) for R1-CEP 2012-170 - Rev 01 of Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il

Looking for Certificates of Suitability (CEPs) for R1-CEP 2012-170 - Rev 01 of Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il 1

20

Teva Pharmaceutical Industries Ltd Tel Aviv - Jaffa Il, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for Teva API has over 350 products in its portfolio and is the leading international supplier of APIs.

One of their significant offerings is Olmesartan medoxomil, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2012-170 - Rev 01

This Chemical Type CEP, issued on May 25, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

Substance Number 2600 associated with this CEP further emphasizes

Post Enquiry
POST ENQUIRY